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ABSTRACT
Malaria is an infectious disease of great importance for Public Health, as it is the most 
prevalent endemic disease in the world, affecting millions of people living in tropical areas 
of the globe. Kidney involvement is relatively frequent in infections by P. falciparum and 
P. malariae, but has also been described in the infection by P. vivax. Kidney complications 
in malaria mainly occur due to hemodynamic dysfunction and immune response. Liver 
complications leading to hepatomegaly, jaundice and hepatic dysfunction can also contribute 
to the occurrence of acute kidney injury. Histologic studies in malaria also evidence 
glomerulonephritis, acute tubular necrosis and acute interstitial nephritis. It is also possible 
to find chronic kidney disease associated with malaria, mainly in those patients suffering 
from repeated episodes of infection. Plasmodium antigens have already been detected in 
the glomeruli, suggesting a direct effect of the parasite in the kidney, which can trigger an 
inflammatory process leading to different types of glomerulonephritis. Clinical manifestations 
of kidney involvement in malaria include proteinuria, microalbuminuria and urinary casts, 
reported in 20 to 50% of cases. Nephrotic syndrome has also been described in the infection 
by P. falciparum, but it is rare. This paper highlights the main aspects of kidney involvement 
in malaria and important findings of the most recent research addressing this issue.
KEYWORDS: Malaria. Kidney disease. Acute kidney injury. Glomerulonephritis. Chronic 
kidney disease.
INTRODUCTION
Malaria is an infectious disease of great interest for Public Health because it 
remains as the most prevalent endemic disease in the world. The etiologic agents 
are parasitic protozoans of the genus Plasmodium. There are four species that 
cause disease in humans in Brazil: P. falciparum, P. vivax, P. ovale and P. malariae. 
P. falciparum causes falciparum malaria, which tend to be a more severe disease. 
P. vivax and P. ovale causes tertian malaria, and P. malariae causes quartan malaria1. 
There can be severe complications, including kidney disease, mainly in infections 
by P. falciparum and P. malariae2.
P. vivax is the most prevalent in tropical regions, and P. falciparum has been 
presenting increasing resistance to some drugs, such as chloroquine. These parasites 
can invade erythrocytes leading to high parasitemia levels, which correlate with 
disease severity and mortality.
Epidemiology
Malaria is endemic in Asia, Africa and Latin America (Figure 1). According to 
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the World Health Organization, its incidence varies from 
200 to 300 million new cases annually, with 200,000 to 
600,000 deaths3. Brazil is responsible for the majority of 
cases in the Americas, with approximately 500,000 cases 
each year, mainly in the Amazon region. In the last years, 
we have observed a decrease in its incidence, going from 
around 300,000 cases in 2003 to 143,000 in 20154. Among 
the main strategies adopted in Brazil in the fight against 
Malaria, there is drug therapy, which is freely available to 
all patients according to guidelines periodically revised by 
experts and the Ministry of Health5.
Malaria outbreaks are generally influenced by 
multifactorial process, including environmental factors 
(vegetation, climate, hydrology), sociodemographic 
(migrations, population density, laboral activity), biological 
(species, Anopheles mosquito density, Plasmodium species, 
degree of the population immunity), and political (territory 
division, healthcare service organization, general infra-
structure of cities)6.
Clinical manifestations
The infection begins when the infective sporozoites 
are inoculated in men by the vector, an insect of the genus 
Anopheles. After some phases of evolutionary cycle, the 
schizonts appear and thousands of merozoites invade 
erythrocytes. The parasites multiply inside erythrocytes 
causing its rupture (hemolysis). The mean incubation time 
is 12 days for P. falciparum, 14 days for P. vivax and 30 days 
for P. malariae, and is usually shorter when the infection is 
acquired through blood transfusion2.
Malaria can be acute, fulminant or chronic. Patients 
present asthenia, anorexia, headache, myalgia, nausea 
and vomiting. The acute form is usually caused by 
P. vivax, P. ovale and, less frequently, by P. malariae. 
Patients present fever, with intervals from 1 to 4 days, 
associated with chills and sweating, anemia, hepatomegaly 
and splenomegaly. Diagnosis can be made through 
microscopy by finding the parasite inside erythrocytes in 
thin or thick blood films. Fulminant malaria is caused by 
P. falciparum, with patient presenting anemia, adynamia, 
diarrhea, jaundice, acute kidney injury, hydroelectrolytic 
disturbances, respiratory failure, disseminated intravascular 
coagulation, shock and coma. Disease reactivation can 
be seen in the infection by P. ovale and P. vivax, due to 
persistence in the liver of quiescent forms, the so-called 
hypnozoites, and manifest with fever reappearance, 
anemia, malnutrition, hepatomegaly and splenomegaly. The 
chronic form is associated with P. malariae, which is the 
parasite most commonly implicated in malaria-associated 
glomerulonephritis, but P. vivax, despite being considered a 
“benign” parasite, resulting in low mortality rates, has also 
been implicated in severe disease7,8. Renal complications in 
P. vivax infections are associated with age, hemodynamic 
disturbances and respiratory failure9. 
Renal involvement in malaria
Malaria was the first parasitic infection to be clearly 
associated with glomerular diseases in tropical areas10. 
Severe malaria can cause disease in glomeruli, tubules 
and in the interstitial region. Kidney disease in malaria 
is primarily due to erythrocyte abnormalities. Parasitized 
red cells tend to adhere to healthy erythrocytes, blood 
platelets and capillary endothelium, leading to formation 
of rosettes and clumps, which impair microcirculation1, 
and these events are probable contributing factors for 
kidney injury, in association with hemodynamic instability, 
including hypovolemia and shock. Endothelial activation 
leads to the release of several cytokines, including 
thromboxane, catecholamines, endothelin and other 
inflammatory mediators that are also implicated in the 
pathogenesis of malaria-associated kidney injury. Immune 
system activation in malaria can go through Th1 and Th2 
response. When Th2 response prevails in the infection by 
P. malariae, complement activation occurs, with deposits 
of immune complexes leading to glomerulonephritis. 
Hemodynamic instability due to intense erythrocyte 
parasitism leads to acute tubular necrosis, as seen in the 
infection by P. falciparum. When Th1 response prevails, 
acute interstitial nephritis and acute glomerulonephritis 
can be seen. Cortical necrosis has also been described in 
malaria, characterizing a more severe kidney injury and 
generally associated with non-recovery of renal function 
and consequently development of end-stage kidney disease8. 
Several factors contribute to the occurrence of these 
complications, including hypovolemia, vasoconstriction, 
hemolysis (leading to hemoglobinuria), erythrocyte 
Figure 1 - Global distribution of malaria transmission, according 
to the Centers for Disease Control and Prevention - CDC. 
Available at: http://www.cdc.gov/malaria/about/distribution.html
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parasitemia, immune complexes deposition in glomeruli, 
microcirculation dysfunction (due to cytoadherence of 
parasite erythrocytes) and rhabdomyolysis (which is not 
common in malaria). Other contributing factor for kidney 
disease in malaria is hepatic dysfunction, with jaundice 
and hepatomegaly, through which hyperbilirubinemia can 
lead to cast nephropathy and acute kidney injury (AKI), 
and liver disease and its complications can also cause AKI 
(hepato-renal syndrome)7,9,11-13.
AKI is reported in the infection by different Plasmodium 
species (P. falciparum, P. vivax, P. malariae and P. ovale), 
and can worsen due to low hydration and fluid loss caused 
by vomiting, pyrexia, sweating and dehydration. Histologic 
studies have showed glomerulonephritis, acute tubular 
necrosis and interstitial nephritis. It is also possible to find 
chronic kidney disease associated with malaria, mainly 
in those patients suffering from repeated episodes of 
infection1,8,14-16.
Kidney involvement by P. falciparum
AKI is a known complication of malaria and can occur in 
around 40% of patients with severe disease by P. falciparum 
in endemic regions, contributing to high mortality rate, 
around 75% of cases12,17,18. P. falciparum causes the most 
severe form of malaria and is responsible for most cases of 
AKI16. In some regions of the globe, malaria is responsible 
for a significant part of patients admitted with AKI (more 
than 10% of cases)15.
Clinical manifestations of P. falciparum malaria-
associated AKI includes oligo-anuria (46-76% of cases), 
severe metabolic acidosis and hypercatabolic state in the 
majority of cases15,16. AKI in these cases occurs in the 
context of severe malaria, and kidney involvement is per 
se one of the criteria for classifying patients as having 
severe falciparum malaria19. Recent studies have found 
as risk factors for AKI in malaria: advanced age, referral 
from another hospital, hyperbilirubinemia, inotropic 
drugs requirement, hospital-acquired secondary infection, 
and factors associated with mortality: advanced age, 
hyperkalemia, jaundice, altered consciousness level, 
leukocytosis, oligo-anuria and P. falciparum infection 
(in comparison with P. vivax infection)16. Electrolyte 
abnormalities include hyponatremia, which seem to be 
frequent in malaria-associated AKI, occurring in 30-50% 
of cases1,15, and hyperkalemia, which is associated with 
hemolysis, rhabdomyolysis and acidosis1, as well as AKI 
per se.
AKI pathogenesis in malaria is not yet fully understood. 
Renal microcirculation blockade due to parasite erythrocytes 
sequestration, immune-mediated glomerular injury and 
volume depletion are possible mechanisms. The main 
kidney histopathological finding in malaria is acute tubular 
necrosis and, less frequently, interstitial nephritis and 
glomerulonephritis, suggesting a key role of hemodynamic 
factors in malaria-associated AKI12.
Glomerulonephritis in patients with P. falciparum 
infection is not common, and it seems that children are 
more likely to be affected by this complication. The exact 
incidence of glomerulonephritis in malaria is not known, 
but it is estimated to be around 18%. Mild proteinuria, 
microalbuminuria and urinary casts are reported in 20 
to 50% of cases. Nephrotic syndrome associated with P. 
falciparum infection is rare. This species is associated with 
acute tubular necrosis, cast nephropathy, inflammatory 
interstitial infiltrate and edema10. The mechanism that leads 
to AKI in malaria is complex and includes mechanic and 
immune factors, cytokines release and acute phase response.
New kidney injury biomarkers have been investigated in 
malaria by P. falciparum, including neutrophil gelatinase-
associated lipocalin (NGAL) and kidney injury molecule-1 
(KIM-1), which have the advantage of detecting AKI 
earlier than traditional markers, such as creatinine. A 
recent study has found evidence that 31% of patients with 
malaria-associated AKI had normal levels of creatinine 
at presentation, illustrating the importance of new AKI 
biomarkers. NGAL seems to be a good biomarker for 
malaria-associated AKI and has already been investigated 
in different types of kidney injury18.
Hypergammaglobulinemia is frequently seen in malaria. 
The infection leads to immunosuppression secondary to 
cytokine production causing depletion of macrophages and 
T cells, which is triggered when the organism interacts with 
the innate immune system that in turn will activate B cells, 
which will produce immunoglobulins. The production of 
immunoglobulins leads to immune complex formation, 
which is related to glomerular injury. The molecular 
mechanisms involved in malarial nephropathy are still being 
discussed, and it is suggested that there is participation of 
TNF-α, IL-1α, IL-6, IL-10 and granulocyte-macrophage 
colony-stimulating factor (GM-CSF)1,10.
There are few studies about glomerular involvement in 
P. falciparum infection. Glomerular basement membrane 
abnormalities are usually absent. It is possible to find 
parasitized erythrocytes in vessel lumen and inflammatory 
infiltrate in renal tissue. Some studies have found evidence 
of glomerular lesions in P. falciparum infection, and they are 
characterized by prominent mesangial proliferation, with 
mild mesangial matrix expansion and occasional thickening 
of basal membrane, with granular eosinophilic material 
deposition in endothelium, mesangium and Bowman’s 
capsule20.
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Through immunofluorescence IgM, IgG and C3 deposits 
have been identified in P. falciparum malaria. More recent 
studies have also found IgA deposits in malaria-associated 
AKI, with resolution after the acute phase of the infection21,22, 
as illustrated in Figure 2. Eosinophilic glomerulonephritis has 
also been found in children with P. falciparum infection23 
(Figure 3). Electronic microscopy findings evidence the 
presence of electron-dense deposits in subendothelial 
and mesangial region, associated with the presence of 
granular, fibrilar and amorphous material. Autoantibodies 
have also been detected in patients with malaria-associated 
glomerulonephritis, but its role has yet to be determined24.
Tubular abnormalities in malaria include granular 
deposits of hemosiderin and the presence of urinary casts, 
associated with mononuclear cells infiltrate and interstitial 
edema, besides acute tubular necrosis (ATN) caused by 
hemodynamic instability. ATN occurs in 1 to 4% of cases 
of P. falciparum infection. The oliguric phase can last a 
few days to weeks and is characterized by microcirculation 
abnormalities, such as peripheral vasodilation, and can 
be associated -with hemolysis, rhabdomyolysis and 
disseminated intravascular coagulation. Oxygen reactive 
species, TNF-α, and nitric oxide also contribute- to the 
hemodynamic disturbances. Relative hypovolemia leads 
to an increase in catecholamine, renin, vasodilators 
prostaglandins and vasopressin, which contributes to 
AKI development. Interstitial nephritis is one of the 
most frequent manifestations of P. falciparum infection-
associated nephropathy, which can be considered as a 
consequence of the host’s immune response to infection20.
Hemolytic-uremic syndrome (HUS) is also described 
in malaria, but its mechanisms are still poorly understood. 
High serum levels of cytokines are possibly related to this 
complication. Malaria specific treatment leads to recovery 
from HUS, evidencing the causal role of infection for HUS 
development25.
Kidney involvement by 
P. malariae infection usually does not cause severe 
disease, but can be associated with renal complications, 
including AKI and glomerulopathies26. Proteinuria is found 
in around 46% of cases, and is occasionally associated 
with microhematuria. Complement levels are normal, 
and there are deposits of immune complexes, leading to 
mesangiocapillar glomerulonephritis and, in some cases, 
nephrotic syndrome that develops some weeks after the 
beginning of infection. Clinical manifestations occur in two 
ways: a benign pattern, with mild and transitory proteinuria, 
without renal function derangement, appearing in the 
second or third week of infection, and a severe pattern, 
with persistent proteinuria or nephrotic syndrome. The most 
common glomerular disease associated with P. malariae 
infection is the membranoproliferative glomerulonephritis. 
An electron microscopy study has shown the thickening 
of glomerular capillary walls caused by subendothelial 
deposits, with “tram track” appearance and mesangial 
proliferation23. Immunofluorescence has shown granular 
deposits through the endothelium with IgG, IgM, C3 
and parasite’s antigens deposits. Proliferative lesions, 
involving mainly the mesangium, are frequent, with crescent 
formation in rare cases. The initial lesion is focal and can 
evolve to glomerular sclerosis. As in other parasitic diseases, 
glomerular lesion progression in malaria depends on many 
factors and requires the association between immune 
Figure 3 - Kidney biopsy from a patient with P. falcifarum-
associated glomerulonephritis: A) Eosinophilic diffuse 
proliferative glomerulonephritis (hematoxylin and eosin 
staining); B) One glomerulus showing some eosinophils 
(arrows). Reproduced by Walker et al.23, with permission. ©2007 
Elsevier – The International Society of Nephrology
Figure 2 - Kidney biopsy from a patient with P. falcifarum-
associated immunoglobulin A (IgA) nephropathy: A) The 
renal biopsy specimen showed mild mesangial proliferation 
and expansion (original magnification × 400); B) Acute and 
chronic inflammatory cell infiltration in the tubulointerstitium 
with multifocal hemosiderin casts (original magnification × 200); 
C) Direct immunofluorescence showed mesangial staining for 
IgA (2+); D) Electron microscopy showed multifocal electron-
dense deposits within the mesangium and irregularly thickened 
glomerular basement membrane ranging from 800 nm to 1,200 
nm in thickness. Diffusely effaced foot processes were also 
observed. Reproduced by Yoo et al.21, with permission. © 2012 
The Korean Academy of Medical Sciences
Rev Inst Med Trop São Paulo. 2017;59:e53
Kidney involvement in malaria: an update
Page 5 of 6
complexes deposits and other aspects such as genetic 
factors of the host and pathogenic mechanism associated 
with the infection.
Rapidly progressive glomerulonephritis associated 
with P. malariae infection is not common, but has 
been observed in endemic areas. There is no specific 
clinical presentation for this condition in malaria. Micro-
hematuria is occasionally observed in older patients, 
nephritic syndrome occurs with variable incidence, and 
hypertension can be seen as a late manifestation. The 
disease can evolve despite parasite elimination, causing 
chronic kidney disease, detectable after 3 to 5 years of 
primary infection10.
AKI due to P. vivax infection is not common, 
although recent studies in endemic areas have evidenced 
P. vivax infection in 16% of malaria-associated AKI, 
and histologic findings (among 15 patients who have 
undergone biopsies) included acute tubular necrosis, 
cortical necrosis, tubulointerstitial nephritis and crescentic 
glomerulonephritis8.
The pathophysiology of malarial nephropathy is 
illustrated in Figure 4.
Treatment
Treatment of malaria-associated kidney disease includes 
appropriated antimalarial drugs, besides all supportive 
measures that AKI requires (hydroelectrolytic disturbances 
corrections, fluid replacement and dialysis)27,28.
A recent study by Luz et al.5 has evidenced that in 
Brazil there are a variety of therapeutic specific schemes for 
malaria, including drugs that can be used during pregnancy, 
such as chloroquine (as monotherapy). This scheme is also 
preconized in our area due to the high prevalence of P. vivax 
infection, which usually causes a milder disease than that 
observed in infections by other Plasmodium species.
Chloroquine is the drug of choice for treatment of 
uncomplicated malaria, although there is already resistance, 
mainly for P. falciparum, against which therapy should 
include primaquine, quinine or mefloquine. To guarantee 
a good efficacy and low toxicity, it is necessary to adjust 
antimalarial drugs doses to the patients’ weight. In malaria 
by P. vivax or P. ovale it is also necessary to include 
primaquine, to eradicate hypnozoites. All antimalarial drugs 
can induce hemolysis in patients with G-6-PD deficiency, 
mainly when the intravenous route is used, leading to 
unknown origin fever. Quinine and chloroquine interacts 
with cyclosporine so that renal transplant patients require 
higher doses of these antimalarials to maintain adequate 
serum concentrations of the drugs19.
For severe malaria treatment, the World Health 
Organization recommends the use of intravenous or 
intramuscular antimalarial drugs, and the most effective 
drug for this purpose is artesunate, which should be 
administered for at least 24 h and until patients can 
tolerate oral medication. The available formulation is the 
artesunic acid in powder, which should be dissolved in 
sodium bicarbonate (5%) to form sodium artesunate. This 
solution in then diluted in 5 mL of 5% dextrose and given 
intravenously or intramuscularly19.
Renal replacement therapy (dialysis) should be 
considered in AKI treatment, with hemodialysis being 
more effective. Dialysis is required in 46 to 76% of cases, 
and complete renal function recovery is reported to occur 
in approximately 64% of cases in both P. falciparum and 
P. vivax malaria-associated AKI8,15. Antimalarial drugs 
are not adequately depurated in hemofiltration dialysis, 
so dialysis does not interfere with the specific treatment 
of malaria. Early initiation of dialysis, for any AKI cause, 
has been associated with better outcomes, and a recent 
meta-analysis found a 25% reduction in all-cause mortality 
and 30% increase in renal recovery among patients with 
AKI receiving early renal replacement therapy29, so we 
recommend early dialysis initiation for AKI associated 
with severe malaria.
Vaccines for malaria are being developed and tested, so 
it is possible that in a near future the burden of the disease 
decreases, as well as renal complications30. 
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